ATE447944T1 - Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere - Google Patents

Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere

Info

Publication number
ATE447944T1
ATE447944T1 AT05763090T AT05763090T ATE447944T1 AT E447944 T1 ATE447944 T1 AT E447944T1 AT 05763090 T AT05763090 T AT 05763090T AT 05763090 T AT05763090 T AT 05763090T AT E447944 T1 ATE447944 T1 AT E447944T1
Authority
AT
Austria
Prior art keywords
formoterol
prophylactic
diabetes
aids
cancer
Prior art date
Application number
AT05763090T
Other languages
English (en)
Inventor
Huguet Jose Maria Argiles
Soriano Francisco Javier Lapez
Rius Silvia Busquets
Original Assignee
Acacia Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acacia Pharma Ltd filed Critical Acacia Pharma Ltd
Application granted granted Critical
Publication of ATE447944T1 publication Critical patent/ATE447944T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • AIDS & HIV (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05763090T 2004-06-29 2005-06-28 Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere ATE447944T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200401941A ES2245612B1 (es) 2004-06-29 2004-06-29 Nuevo uso terapeutico del formoterol.
PCT/ES2005/000365 WO2006003222A1 (es) 2004-06-29 2005-06-28 Uso del formoterol en el tratamiento profiláctico y/o terapéutico del desgaste muscular y/o síndrome caquéctico, asociados a estados catabólicos de ciertas enfermedades como cáncer, sida, infecciones, diabetes y otras

Publications (1)

Publication Number Publication Date
ATE447944T1 true ATE447944T1 (de) 2009-11-15

Family

ID=35614437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05763090T ATE447944T1 (de) 2004-06-29 2005-06-28 Verwendung von formoterol in der prophylaktischen und/oder therapeutischen behandlung von muskelschwund und/oder kachexie-syndrom im zusammenhang mit katabolischen zuständen bei bestimmten krankheiten, wie z.b. krebs, aids, infektionen, diabetes und andere

Country Status (9)

Country Link
EP (1) EP1818052B1 (de)
AT (1) ATE447944T1 (de)
CY (1) CY1109771T1 (de)
DE (1) DE602005017659D1 (de)
DK (1) DK1818052T3 (de)
ES (2) ES2245612B1 (de)
PL (1) PL1818052T3 (de)
PT (1) PT1818052E (de)
WO (1) WO2006003222A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
AU2008240379B2 (en) * 2007-04-24 2012-10-04 Acacia Pharma Limited Drug combination of beta 2 agonist and a progestin for the treatment of muscle loss
CN117562998A (zh) * 2023-02-02 2024-02-20 上海市第十人民医院 长效β2AR激动剂在制备治疗癌症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
WO2002066027A1 (de) * 2001-02-22 2002-08-29 Universitätsklinikum Charite Medizinische Fakultät Der Humboldt-Universität Zu Berlin, Akademische Verwaltung - Forschung Mittel zur hemmung von tumorzellen

Also Published As

Publication number Publication date
EP1818052A1 (de) 2007-08-15
CY1109771T1 (el) 2014-09-10
ES2245612B1 (es) 2007-08-16
WO2006003222A9 (es) 2009-01-15
PL1818052T3 (pl) 2010-04-30
EP1818052B1 (de) 2009-11-11
DE602005017659D1 (de) 2009-12-24
WO2006003222A1 (es) 2006-01-12
DK1818052T3 (da) 2010-03-29
ES2336229T3 (es) 2010-04-09
PT1818052E (pt) 2010-02-15
ES2245612A1 (es) 2006-01-01

Similar Documents

Publication Publication Date Title
NO20050807L (no) Farmasoytiske sammensetninger som innbefatter dekstrometorfan og kinidin for behandling av neurologiske forstyrrelser
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
EA200501095A1 (ru) Фенилацетамиды и их применение в качестве модуляторов глюкокиназы
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
CL2003002353A1 (es) Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
ATE531382T1 (de) Behandlungsmethoden von entzündungskrankheiten mit spezifisch an menschliches angiopoietin-2 bindenden wirkstoffen
AR045870A1 (es) Terapia de combinacion para la infeccion de virus de hepatitis c
DE60335647D1 (de) Pyrroloquinoline quinone und ein betablocker zur behandlung von ischämie oder reperfusionsschäden
MXPA05001885A (es) El uso de una combinacion de ciclesonida y antihistaminas para el tratamiento de la rinitis alergica.
ECSP055844A (es) Nuevos compuestos triciclicos
ATE380554T1 (de) Verwendung von xenon mit hypothermie zur behandlung von neugeborenen-asphyxie
CY1109771T1 (el) Η χρηση της φορμοτερολης στην προφυλακτικη και/ή θεραπευτικη αντιμετωπιση της μυικης απωλειας και/ή του καχεκτικου συνδρομου τα οποια συνδεονται με τις καταβολικες συνθηκες ορισμενων παθησεων. οπως ο καρκινος, to aids, οι μολυνσεις, ο διαβητης και αλλες
DE60208701D1 (de) Verwendung von cetrorelix zur behandlung vom jakob-creutzfeldt-syndrom
DE602005013542D1 (de) Behandlung der oralen und darm mukositis durch verabreichung von menschlichem il-18
DK1416937T3 (da) Profylaktisk og terapeutisk anvendelse af hydroxysteroider
BR0313665A (pt) Utilização de bupropion para o tratamento da sìndrome das pernas inquietas
CO2023007851A2 (es) Proteínas de unión a il-7 y su uso en tratamientos médicos
IL177169A (en) Use of n-(2-aryl- propionyl)-sulfonamides for the preparation of medicaments for the treatment of spinal cord injury
DE50203154D1 (de) Benzimidazolderivate zur behandlung von mit mikroglia-aktivierung assoziierten erkrankungen wie inflammatorische, allergische, infektiöse oder autoimmune erkrankungen
WO2007117272A3 (en) Methods for treatment of hemorrhagic shock and related disorders
RU2004128515A (ru) Способ восстановления кожного покрова при комбинированных радиационно-ожоговых поражениях
FI20021180A7 (fi) Lääketieteellisen tutkimus- ja käsittelypöydän jatkesovitelma
RU2003135700A (ru) Способ лечения хирургической инфекции
RU2005132559A (ru) Способ профилактики и лечения радиоэпителиитов полости рта

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1818052

Country of ref document: EP